Jiangsu Jibeier Pharmaceutical (SH:688566) Shang Hai Zheng Quan Bao·2025-09-26 18:30Group 1 - The core point of the announcement is the resolution of the second extraordinary general meeting of shareholders held by Jiangsu Jibeier Pharmaceutical Co., Ltd. on September 26, 2025, which included the approval of a significant amendment to the company's governance structure [1][2]. - The meeting was conducted in compliance with the Company Law and the company's articles of association, with a combination of in-person and online attendance [2][4]. - All current directors and supervisors attended the meeting, ensuring full representation of the board [3]. Group 2 - A key resolution passed during the meeting was the proposal to abolish the supervisory board and amend the company's articles of association and certain governance systems, which received more than two-thirds of the valid votes from attending shareholders [4]. - The legal proceedings of the meeting were witnessed by Beijing Jindu (Nanjing) Law Firm, confirming that all procedures adhered to legal and regulatory requirements [6].